Who we are

About Us

An integrated industrial group combining the solidity of operational SMEs with the disruptive power of Deep Tech innovation in the healthcare sector.

Who We Are

Biovalley Investments Partner SpA is an innovative SME and integrated industrial group revolutionizing the healthcare sector by combining the solidity of operational companies with the disruptive power of high-potential Deep Tech innovation.

Founded in 2016 in Trieste, the company has leveraged the rich scientific ecosystem of Trieste — where researcher density is 4 times higher than the EU/USA average — to build a unique portfolio of companies and technologies in the health sector.

Biovalley operates through two main Business Units: BioTech & Pharma, focused on biosimilar drugs, pharmaceutical robotics and orphan drugs; and BioICT, which develops medical informatics solutions and artificial intelligence for private healthcare facilities.

The company is recognized as an innovative SME under Italian law and has obtained ISO 9001 certification. The company is planning to list on Euronext Growth Paris in 2026.

2016
Year of foundation in Trieste
Innovative SME
Recognized under Italian law (D.L. 179/2012) and ISO 9001 certified
€11,558,593.40
Share capital, fully paid up
IPO 2026
Target listing on Euronext Growth Paris

The Model

The Strategy

Pillar 1
Stable Organic Expansion

Recurring revenues from operational SMEs with high customer retention

+
Pillar 2
Deep Tech Innovation

Exponential growth from patented disruptive technologies

=
Result
Dual Growth Model

Financial solidity + exponential growth potential

Biovalley strategy: stable organic expansion + Deep Tech innovation + research ecosystem

Group Structure

BIP SpA operates as a holding company for an integrated portfolio of healthcare companies.

Biovalley Investments Partner SpA
Parent holding company · Trieste, Italy
BioTech & Pharma
  • Serichim (85.5%)
  • BIP Pharma Division
  • ChemoMaker® BU
  • LOHCATE Srl
BioICT
  • CB Sistemi & Multimedia
  • TriesteValley
  • BIC Incubatori FVG

Management Team

A team with proven experience in creating value in the technology and healthcare sector.

Eng. Diego Bravar

Eng. Diego Bravar

Founder & President

Founder of TBS Group (listed on AIM Milan), sold for €100 million in 2017 and subsequently resold by the new owner for €1 billion in 2022 (value multiplied by 10 in five years). Professor at the University of Trieste and Vice President of Confindustria Alto Adriatico.

Eng. Francesco Menegoni

Eng. Francesco Menegoni

CEO

PhD in Bioengineering from Politecnico Milano, founder of G&Life (a BIP subsidiary), formerly an Innovation Expert at the Presidency of the Council of Ministers (Department of Digital Transformation).

Dr. Andrea Zacchigna

Dr. Andrea Zacchigna

CFO

Experience in management control and finance at Insiel Mercato and GPI SpA (a listed healthcare IT company).

Company Details

Company Name
Biovalley Investments Partner SpA
Registered Office
Via Flavia 23/1 - 34148 Trieste, Italy
VAT / Tax ID
IT01279490328
SDI Code
USAL8PV
REA
TS-138029
Share Capital
€11,558,593.40 fully paid up
PEC
biovalleypartner@legalmail.it
Certifications
Innovative SME · ISO 9001